Scrip Awards 2022 | Informa | Royal Lancaster London, Lancaster Terrace, London W2 2TY, UK

Now in its 18th year, the Scrip Awards brings together over 400 industry leaders to celebrate and recognise the very best innovations and achievements in global biopharma. Winners will be celebrated across 15 categories, covering a full spectrum of advancements, from Best New Drug, Community Partnership of the Year, Clinical Advance of the Year and Best Contract Research Organisation.

Categories
• Best New Drug Award
• Clinical Advance Of The Year
• Wuxi Apptec’s Biotech Company Of The Year
• China Biopharma Leadership Award
• Community Partnership Of The Year
• Executive Of The Year
• Licensing Deal Of The Year
• Business Development Team Of The Year
• Best Contract Research Organisation – Full-service Providers
• Best Contract Research Organisation – Specialist Providers
• Best Partnership Alliance
• Financing Deal Of The Year
• MSD’s Innovation Award
• Pharma Company Of The Year
• Lifetime Achievement Award

2021 Winners

MSD's Innovation Award – Sponsored by MSD
• Moderna’s mRNA vaccine technology

China Biopharma Leadership Award
• BeiGene China

Financing Deal of the Year
• Amphista Therapeutics’ $53m series B

Clinical Advance of the Year – Sponsored by Parexel
• Takeda Pharmaceutical Company's Phase III SOLSTICE trial of maribavir in transplant recipients with CMV infection

Business Development Team of the Year
• Evox Therapeutics

Best Partnership Alliance
• BenevolentAI and AstraZeneca for AI and machine learning to discover potential new treatments for chronic kidney disease and idiopathic pulmonary fibrosis

Best Contract Research Organization - Specialist Providers
• MMS Holdings

Best Contract Research Organization - Full Service Providers – Sponsored by Clario, an ERT Company
• ICON

Licensing Deal of the Year
• Roche and Regeneron for the development, manufacture and commercialization of REGN-COV2 for COVID-19

Community Partnership of the Year
• Accord Healthcare and International Health Partners

Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award – Sponsored by Parexel
• CluePoints, BioNTech and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty)

Moderna’s Phase III COVE study of mRNA-1273 for COVID-19 prevention

Best New Drug - COVID-19 Pandemic Special Recognition Award
• AstraZeneca’s Vaxzevria COVID-19 Vaccine
• BioNTech and Pfizer’s Comirnaty (BNT162b2)
• Johnson & Johnson’s single-dose COVID-19 Vaccine
• Moderna’s COVID-19 Vaccine (mRNA1273)

Executive of the Year - Development-stage or companies with a market cap of <$5bn
• Jingwu Zang, founder, chairman and director of I-Mab

Executive of the Year - Commercial-stage and companies with a market cap of >$5bn
• John V Oyler, co-founder, chairman and chief executive officer of BeiGene

WuXi AppTec's Biotech Company of the Year Award – Sponsored by WuXi AppTec
• ADC Therapeutics

Best New Drug Award - non COVID-19
• GlaxoSmithKline’s Blenrep (belantamab mafodotin) for multiple myeloma

Pharma Company of the Year – Sponsored by IQVIA
• Moderna

Scrip's Lifetime Achievement Award – Sponsored by ICON
• Dame Kate Bingham and Clive Dix